Does TAZEMETOSTAT HYDROBROMIDE Cause Malignant neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Malignant neoplasm progression have been filed in association with TAZEMETOSTAT HYDROBROMIDE (TAZVERIK). This represents 1.4% of all adverse event reports for TAZEMETOSTAT HYDROBROMIDE.
18
Reports of Malignant neoplasm progression with TAZEMETOSTAT HYDROBROMIDE
1.4%
of all TAZEMETOSTAT HYDROBROMIDE reports
7
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TAZEMETOSTAT HYDROBROMIDE?
Of the 18 reports, 7 (38.9%) resulted in death, 5 (27.8%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAZEMETOSTAT HYDROBROMIDE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TAZEMETOSTAT HYDROBROMIDE Cause?
Off label use (298)
Fatigue (292)
Disease progression (267)
Nausea (207)
Product dose omission issue (183)
Death (106)
Diarrhoea (100)
Decreased appetite (81)
Asthenia (75)
Vomiting (75)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TAZEMETOSTAT HYDROBROMIDE Alternatives Have Lower Malignant neoplasm progression Risk?
TAZEMETOSTAT HYDROBROMIDE vs TAZOBACTAM
TAZEMETOSTAT HYDROBROMIDE vs TBO-FILGRASTIM
TAZEMETOSTAT HYDROBROMIDE vs TEBENTAFUSP-TEBN
TAZEMETOSTAT HYDROBROMIDE vs TECFIDERA
TAZEMETOSTAT HYDROBROMIDE vs TECHNETIUM TC-99M